A 43-year-old woman presented to a rheumatology clinic with a 6-month history of progressive swelling of her lower legs and pain in her knees and ankles. She had no pre-existing medical conditions and was a nonsmoker. She had not been unwell. In particular, she had no constitutional, cardiac, gastrointestinal or respiratory symptoms such as cough, fever, dyspnea or hemoptysis. On physical examination, she had bilaterally warm and tender knees and ankles, and clubbing of her fingers and toes ( Figure 1) . The results of laboratory investigations including a complete blood count, urinalysis and hepatic and renal tests were normal. Rheumatoid arthritis was diagnosed, but therapy with oral nonsteroidal antiinflammatory drugs only marginally improved the patient's pain. The rheumatoid factor was normal, and results of tests for both antinuclear antibodies and anticyclic citrullinated peptide antibodies were negative. Because of the clubbing, we ordered pulmonary function tests and echocardiography, the results of which were normal. At follow-up 6 months later, a chest radiograph showed a large lesion in the lower lobe of the left lung ( Figure 2 ). 
Which diagnosis is most likely?

Discussion
The answer is (e) hypertrophic pulmonary osteoarthropathy. We diagnosed pulmonary adenocarcinoma after biopsy of the lung mass. A computed tomography scan of the chest showed a pulmonary tumour 3.5 cm in diameter on the lower lobe of the left lung. A computed tomography scan of the patient's brain did not show a metastatic tumour, and we did not find lymph node metastases during the surgical dissection. Arthralgia of the knee and ankle joints improved 4 months after resection of the tumour.
Hypertrophic pulmonary osteoarthropathy: Hypertrophic pulmonary osteoarthropathy is a paraneoplastic syndrome characterized by clubbing of the fingers or toes, periostitis of the long bones, or arthritic symptoms in the wrists, elbows, knees and ankles.
1
Radiographs of bones may disclose a solid periosteal reaction along the long bones, such as tibial, fibular or femoral shafts. Whole-body bone scintigraphy shows a characteristic pattern and is the preferred method for diagnosing the syndrome (Figure 3 ). Hypertrophic pulmonary osteoarthropathy is often associated with primary or metastatic pulmonary cancer, most commonly primary pulmonary adenocarcinoma.
2 Some abdominal cancers are also associated with the disease. Although the cause is not fully understood, increased blood flow in the long bones has been described, as well as elevations of tumour-associated factors, including growth hormone, transforming growth factor β-1, vascular endothelial growth factor and plasma endothelin.
3
Treatment of hypertrophic pulmonary osteoarthropathy relies on treatment of the primary lesion. Hypertrophic pulmonary osteoarthropathy related to lung cancer has been reported to be improved or, in some cases, remitted completely after resection of the primary lesion.
Differential diagnosis:
Granulomatous diseases, including Wegener granulomatosis, may cause local or systemic involvement and are characterized by histiocyte inflammation and granuloma formation. Wegener granulomatosis 4 involves the upper and lower respiratory tracts and the kidneys. Chest radiographs may show infiltrates and nodules with or without cavities. Oral ulcers, nasal secretions, abnormal urinary sediments and serum antineutrophil cytoplasmic antibodies are diagnostic clues. Wegener granulomatosis is sometimes associated with arthralgia.
Systemic lupus erythematosus is an autoimmune disease in which polyarthritis is common. Over 90% of patients experience joint symptoms during the course of illness. If the lungs are involved, chest radiography tends to be consistent with pleural effusion, interstitial lung disease or pulmonary hemorrhage.
Rheumatoid arthritis commonly results in interstitial pulmonary abnormalities, but other lung manifestations include pleural disease, obstructions of the small or large airways, or, less frequently, pulmonary rheumatoid nodules. Anticyclic citrullinated peptide antibodies are 88% sensitive and 89% specific for rheumatoid arthritis. 
